Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca
Go back to Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca| Pfizer Inc. (NYSE: PFE) | Delayed: 25.01 +0.10 (0.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.91 | 52 Week High | $37.39 | |||
| Open | $24.82 | 52 Week Low | $28.25 | |||
| Day High | $25.18 | P/E | 15.16 | |||
| Day Low | $24.67 | EPS | $1.65 | |||
| Volume | 45,075,387 | |||||
| Sumitomo Chemical Co Ltd Unsponsored ADR (AMEX: SOMMY) | Delayed: 15.35 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.35 | 52 Week High | $30.01 | |||
| Open | $15.35 | 52 Week Low | $19.54 | |||
| Day High | $15.35 | P/E | N/A | |||
| Day Low | $15.35 | EPS | $0.00 | |||
| Volume | 122 | |||||
